Cooper Heart Institute Department News
Joseph E. Parrillo, M.D., director of the Cooper Heart Institute is being recognized by the American College of Chest Physicians as an Honor Lecture Recipient for Chest 2004. Dr. Parrillo will present the Roger C. Bone Memorial Lecture entitled: Reversible Causes of Severe Myocardial Dysfunction: Ischemia, Sepsis and Myocarditis- Mechanisms and Treatment.
Augustine Agocha, M.D., Ph.D., director of the Cooper Heart Institute’s Nuclear Cardiology Program has been selected to the steering committee of the National Coalition for the management of Left Ventricular Dysfunction (NCLVD). The mission of the NCLVD is to provide current, multidisciplinary information and educational tools regarding comprehensive treatment for heart failure.
Anand Kumar, M.D., Sergio Zanotti, M.D. and Joseph Parrillo, M.D. were among the authors of an article published in Critical Care Medicine 2004, Volume 32, Number 3., entitled: “Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects.”
The 6th Annual Research Week at Cooper University Hospital resulted in an unprecedented sweep of the top four awards by the Division of Cardiovascular Disease. The cardiovascular fellowship program participants received awards for the following research:
- 1st prize-Michael Reinig, M.D.: Hypertensive responses to exercise/angiographic correlation
- 2nd prize-George Kaddissi, M.D.: Stent vessel relationship in the drug-eluting stent era concordance or discordance
- 3rd prize-Neeta Tripathi, M.D.: Phyisiologic and hemodynamic differences between adenosine with and without low-level treadmill exercise testing and patients complaining of dyspnea
- 4th prize-Vijayendra Verma, M.D.: Impaired endothelial function correlates with coronary calcification in asymptomatic peri-menopausal women
Area Cardiologist Joins Cooper Heart Institute
Responding to the growing cardiovascular needs of South Jersey, the Cooper Heart Institute has expanded their cardiology offerings with the recruitment of Brian Pahlow, D.O. A graduate of the University of Medicine and Dentistry, New Jersey School of Osteopathic Medicine (UMDNJ-SOM), Dr. Pahlow completed his internal medicine residency and his cardiology fellowship at UMDNJ-SOM, Stratford. He is board certified in internal medicine and cardiovascular disease.
“Dr. Pahlow is an experienced clinical cardiologist who will be a great asset to our cardiovascular program,” says Joseph Parrillo, M.D., director of the Cooper Heart Institute.
Dr. Pahlow will continue to serve the Salem county area. To speak with Dr. Pahlow, or to refer a patient, please call: (856) 935-6700.
Cardiogenic Shock Trial Underway at Cooper
The Cooper Heart Institute is currently enrolling patients in a novel parenteral therapy for cardiogenic shock complicating myocardial infarction. The SHOCK-2 (SHould we inhibit nitric Oxide synthase in Cardiogenic shocK) Trial is an international, multi-center randomized study of the nitric oxide synthase (NOS) inhibitor LNMMA Injection (NG-Monomethyl L-Arginine Acetate).
Systemic inflammation plays a central role in the pathogenesis and persistence of cardiogenic shock via excess nitric oxide (NO). Two pilot studies have suggested a marked clinical benefit of nitric oxide inhibition with a significant reduction in mortality.
Patients are considered for the trial if shock due to left ventricular failure persists after percutaneous coronary intervention, vasopressors or intra-aortic balloon counterpulsation. Enrollment must also occur within 24 hours of the onset of shock.
For more information about the trial, contact Steven Hollenberg, M.D., director of the Cooper Coronary Care Unit and study principal investigator at Cooper at (856) 342-2227. To arrange transfer for a patient in cardiogenic shock, call the Cooper Transfer System (COTS), 1-866-723-COTS.